Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06388668

Lipid Testing After Myocardial Infarction at the Montreal Heart Institute

Sponsor: Montreal Heart Institute

View on ClinicalTrials.gov

Summary

Because treatment decisions are usually based on a single measurement of the lipid panel at the time of an admission for an MI, the overarching objective of this project is to evaluate whether the measurement of LDL, non-HDL, and apoB values are reliable through all the duration of the hospitalization. It will be a single-center, prospective, observational study will be conducted, including consecutive patients hospitalized for myocardial infarction at the Montreal Heart Institute. Every patient at the Cardiac Care Unit will undergo non-fasting lipid panel testing at day 0 of their admission for Myocardial Infarction during the study period. Patients who consent to participate will have a 2nd non-fasting lipid panel drawn at day 2 of their admission. Thereafter, the levels of the different lipid values from the panel will be compared between day 0, day 2, and 4-6 weeks after discharge.

Official title: Timing of Lipid Testing During Hospitalization for MI and Subsequent Management of Dyslipidemia An Observational Study to Reduce the Care Gaps in Dyslipidemia in Canada

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

100

Start Date

2024-06-01

Completion Date

2026-05

Last Updated

2025-12-03

Healthy Volunteers

No

Interventions

DIAGNOSTIC_TEST

Lipid panel

Lipid panel measuring levels of LDL, non-HDL and apoB

Locations (2)

Montreal Heart Institute

Montreal, Quebec, Canada

Montreal Heart Institute

Montreal, Quebec, Canada